Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: vorinostat|GENETIC: protein expression analysis|OTHER: immunohistochemistry staining method|OTHER: laboratory biomarker analysis|PROCEDURE: neoadjuvant therapy|PROCEDURE: therapeutic conventional surgery
Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)